⌘K

Login Start Free

Home/Filings/4/0001240547-13-000001

4//SEC Filing

KV PHARMACEUTICAL CO /DE/ 4

Accession 0001240547-13-000001

CIK 0000057055operating

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 8:55 PM ET

Size

17.1 KB

Accession

0001240547-13-000001

Insider Transaction Report

Form 4

Period: 2013-09-16

KV PHARMACEUTICAL CO /DE/KVA/KVB

MCHUGH THOMAS S

Chief Financial Officer

Transactions

Other
Option to Purchase
2013-09-16−20,000→ 0 total
Exercise: $1.62Exp: 2020-09-07→ Class A Common Stock (20,000 underlying)
Other
Option to Purchase
2013-09-16−20,000→ 0 total
Exercise: $1.40Exp: 2019-04-09→ Class A Common Stock (20,000 underlying)
Other
Option to Purchase
2013-09-16−25,000→ 0 total
Exercise: $1.14Exp: 2020-07-29→ Class A Common Stock (25,000 underlying)
Other
Option to Purchase
2013-09-16−35,000→ 0 total
Exercise: $1.49Exp: 2021-09-08→ Class A Common Stock (35,000 underlying)
Other
Option to Purchase
2013-09-16−35,000→ 0 total
Exercise: $1.32Exp: 2022-03-28→ Class A Common Stock (35,000 underlying)
Other
Option to Purchase
2013-09-16−5,000→ 0 total
Exercise: $1.52Exp: 2019-04-24→ Class A Common Stock (5,000 underlying)

Footnotes (7)

[F1]On September 16, 2013, the Sixth Amended Joint Chapter 11 Plan of Reorganization of K-V Pharmaceutical Company (the "Company"), which was confirmed by the United States Bankruptcy Court for the Southern District of New York on August 28, 2013, was consummated. As a result, all issued and outstanding shares of the Companys Class A Common Stock, Class B Common Stock and 7% Cumulative Convertible Preferred Stock, and the warrants and options exercisable therefor, were cancelled and extinguished.
[F2]The option was to vest in three equal installments beginning on April 2, 2010.
[F3]The option was to vest in two equal annual installments beginning on December 31, 2009.
[F4]The option was to vest in five equal annual installments beginning on September 7, 2011.
[F5]The option was to vest in five equal annual installments beginning on July 29, 2011.
[F6]The option was to vest in three equal installments beginning on September 8, 2012.
[F7]The option was to vest 33% on March 28, 2013, 33% on March 28, 2014 and 34% on March 28, 2015.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

KV PHARMACEUTICAL CO /DE/

CIK 0000057055

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000057055

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 8:55 PM ET
Size: 17.1 KB

View on SEC.gov